Global network of CAP accredited laboratories. Extensive test menu.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Experience in cardiovascular trials supported by a global team of experts.
ICON has conducted diabetes trials in all global regions.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
Designed to enhance patient engagement and support patient recruitment and retention.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
Risk-adjusted, international benchmarks on health outcomes by medical condition.
The 5 things you need to know about ICH GCP (R2) 2016
BYOD promises greater patient-centricity and will make study management less complex
Insights from ICON professionals on current clinical development issues.
26 - 30 JunePennsylvania Convention Center, PhiladelphiaMeet our newly expanded Commercialisation & Outcomes team & hear industry insights at our sessions.
26 - 30 JuneFollow the conversations from global industry thought leaders at DIA with our interactive social media and data visualisation site.
7 - 8 SeptemberSheraton Boston Hotel, BostonSpeak with ICON experts about optimising your clinical development strategies.
From a small team of 5 people in 1990, ICON now employs over 12,200 professionals in 37 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Local knowledge combined with global expertise to ensure quality data on time and within budget.
ICON has assembled a leadership team with unrivaled vision and experience.